SCM
CAMP icon

Sterling Capital Management’s CAMP4 Therapeutics CAMP Stock Holding History

Sterling Capital Management’s Portfolio CAMP Stock Details CAMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$485 Buy
+111
New +$479 ﹤0.01% 3227
2025
Q2 		– Sell
-71
Closed -$284 – 3284
2025
Q1 		$284 Sell
71
-41
-37% -$198 ﹤0.01% 3044
2024
Q4 		$585 Buy
+112
New +$920 ﹤0.01% 3016

Other funds holding CAMP

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return
PWA
Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Sterling Capital Management's CAMP Position: Q2 2026 in Review

Sterling Capital Management opened a new position in CAMP4 Therapeutics (CAMP) in Q2 2026: 111 shares worth $485. The stake represents ﹤0.01% of the portfolio and ranks #3227 among its holdings. This is a return to the name: Sterling Capital Management previously reported a position in CAMP as recently as Q1 2025.

Sterling Capital Management first reported a position in CAMP in Q4 2024 and has held it in 3 quarters since. The position peaked at $585 in Q4 2024. 7 funds tracked by Wall St. Rank hold CAMP as of Q2 2026.

  • Sterling Capital Management held 111 shares of CAMP4 Therapeutics worth $485 as of Q2 2026.
  • CAMP4 Therapeutics was a new Sterling Capital Management position in Q2 2026.
  • CAMP4 Therapeutics made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #3227 holding.
  • Sterling Capital Management first reported a position in CAMP4 Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • Sterling Capital Management's CAMP4 Therapeutics position peaked at $585 in Q4 2024.
  • 7 funds tracked by Wall St. Rank held CAMP4 Therapeutics as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.